We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $15.6B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.2B
AUM Growth
+$326M
Cap. Flow
+$206M
Cap. Flow %
1.46%
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Technology 14.39%
3 Miscellaneous 12.72%
4 Industrials 12.27%
5 Healthcare 11.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESAB icon
501
ESAB
ESAB
$4.79B
$887K 0.01%
9,176
+5,720
+166% +$663K
BDC icon
502
Belden
BDC
$4.48B
$882K 0.01%
7,684
+1,962
+34% +$247K
GSHD icon
503
Goosehead Insurance
GSHD
$1.71B
$879K 0.01%
20,599
-167,672
-89% -$9.38M
NUE icon
504
Nucor
NUE
$56.9B
$869K 0.01%
+5,137
New +$895K
TRIP icon
505
TripAdvisor
TRIP
$1.16B
$867K 0.01%
+81,374
New +$948K
MOS icon
506
The Mosaic Company
MOS
$7.49B
$841K 0.01%
32,965
-69,545
-68% -$1.91M
CALM icon
507
Cal-Maine
CALM
$3.79B
$838K 0.01%
10,592
-4,230
-29% -$347K
BANF icon
508
BancFirst
BANF
$3.71B
$837K 0.01%
+7,712
New +$857K
DCI icon
509
Donaldson
DCI
$10.6B
$827K 0.01%
+9,739
New +$941K
PCRX icon
510
Pacira BioSciences
PCRX
$1.03B
$823K 0.01%
36,422
-410
-1% -$9.11K
UPBD icon
511
Upbound Group
UPBD
$1.13B
$818K 0.01%
45,314
+26,152
+136% +$510K
ZBRA icon
512
Zebra Technologies
ZBRA
$16.9B
$812K 0.01%
3,883
+2,227
+134% +$523K
CRUS icon
513
Cirrus Logic
CRUS
$5.44B
$810K 0.01%
+5,602
New +$754K
TGTX icon
514
TG Therapeutics
TGTX
$8.3B
$810K 0.01%
24,379
+9,633
+65% +$287K
HQY icon
515
HealthEquity
HQY
$7.91B
$809K 0.01%
+9,683
New +$794K
TPB icon
516
Turning Point Brands
TPB
$1.7B
$807K 0.01%
+9,303
New +$1.04M
KNSA icon
517
Kiniksa Pharmaceuticals
KNSA
$6.13B
$802K 0.01%
+16,660
New +$738K
UTZ icon
518
Utz Brands
UTZ
$1.26B
$797K 0.01%
+100,598
New +$935K
INSW icon
519
International Seaways
INSW
$4.91B
$790K 0.01%
10,843
+1,994
+23% +$128K
ST icon
520
Sensata Technologies
ST
$6B
$787K 0.01%
22,354
+858
+4% +$30.4K
UNP icon
521
Union Pacific
UNP
$183B
$780K 0.01%
3,216
-13,842
-81% -$3.39M
EXPO icon
522
Exponent
EXPO
$3.4B
$778K 0.01%
+11,925
New +$847K
SHC icon
523
Sotera Health
SHC
$5.51B
$776K 0.01%
+54,111
New +$898K
SKYW icon
524
Skywest
SKYW
$3.82B
$772K 0.01%
8,411
-8,481
-50% -$836K
PRI icon
525
Primerica
PRI
$8.99B
$770K 0.01%
3,074
+2,257
+276% +$582K

Similar funds

Freestone Grove Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.

  • Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
  • Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
  • Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
  • Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
  • Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
  • Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
  • Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.